Palisade Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:7NS0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 May 24Buy€4,471Donald WilliamsIndividual1,000€4.47
24 May 24Buy€4,431J. FinleyIndividual1,000€4.43
06 Feb 24Buy€4,366J. FinleyIndividual666.67€6.55
31 Jan 24Buy€5,576Donald WilliamsIndividual666.67€8.36
31 Jan 24Buy€5,152J. FinleyIndividual666.67€7.73

Insider Trading Volume

Insider Buying: 7NS0 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 7NS0?
Owner TypeNumber of SharesOwnership Percentage
Private Companies510.00545%
Institutions16,4341.76%
Individual Insiders21,4422.29%
Hedge Funds85,1009.09%
General Public813,37586.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 109.7%.


Top Shareholders

Top 25 shareholders own 13.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.09%
Armistice Capital LLC
85,100€359.7k77.3%0.01%
1.44%
J. Finley
13,472€56.9k109%no data
0.48%
The Vanguard Group, Inc.
4,536€19.2k0%no data
0.41%
Mitchell Jones
3,852€16.3k654%no data
0.36%
Donald Williams
3,340€14.1k67%no data
0.26%
Yuma Regional Medical Center, Endowment Arm
2,419€10.2k0%no data
0.25%
Geode Capital Management, LLC
2,296€9.7k0%no data
0.23%
Hudson River Trading LLC, Asset Management Arm
2,155€9.1k0%no data
0.2%
Two Sigma Securities, LLC, Asset Management Arm
1,880€7.9k43.5%no data
0.16%
State Street Global Advisors, Inc.
1,497€6.3k0%no data
0.13%
Millennium Management LLC
1,213€5.1k0%no data
0.05%
Binxian Wei
467€2.0k15,500%no data
0.031%
Robert McRae
289€1.2k-0.34%no data
0.016%
UBS Asset Management AG
148€625.7-11.9%no data
0.015%
Morgan Stanley, Investment Banking and Brokerage Investments
140€591.60%no data
0.011%
Fédération des Caisses Desjardins du Québec, Asset Management Arm
100€422.70%no data
0.0054%
Fcw Investments Llc
51€215.7-1.92%no data
0.0024%
Wells Fargo & Company, Securities and Brokerage Investments
22€93.04.76%no data
0.0021%
Michael Dawson
20€84.70%no data
0.002%
Orion Capital Management LLC
19€80.30%no data
0.00053%
Wells Fargo & Company, Private Banking and Investment Banking Arm
5€21.025%no data
0.00021%
Thomas Hallam
2€8.30%no data
0.00021%
BFS Wealth Management, LLC
2€8.30%no data
0.00011%
BlackRock, Inc.
1€4.40%no data
0.00011%
Strategic Advisers LLC
1€4.4-50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/07/03 15:38
End of Day Share Price 2024/04/05 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Palisade Bio, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Aydin HuseynovLadenburg Thalmann & Company
Jason McCarthyMaxim Group